blog

Compliance is often seen as a cost centre— a regulatory obligation that drains resources; I’d like to redefine it as a strategic enabler of financial resilience and commercial value. Cost Efficiency Through Reduced Disruptions QA-related issues such as downtime, failed inspections, or delayed approvals heavily impact budgets. Between June 2012 and September 2023, the FDA […]

In the dynamic landscape of the pharmaceutical industry, the Medical Information (MI) function plays a pivotal role in delivering accurate, timely, and compliant information to healthcare professionals (HCPs), patients, and stakeholders. However, ensuring compliance in this area is increasingly complex, with regulatory scrutiny, technological advancements, and rising patient expectations creating significant challenges. This blog post

Congratulations, you’ve made it! After years of R&D, clinical trials, and regulatory submissions, your small biotech has finally secured its first commercial product approval. The hard work is done, right? Not so fast. As you pivot from a development-focused organization to a commercial one, a new and critical function takes center stage: Medical Information. This

Discover strategies to optimize and maintain a Pharmacovigilance QMS in 2025, ensuring global compliance, efficiency, and patient safety across diverse markets. In the ever-evolving landscape of pharmaceutical and biotech industries, a robust Pharmacovigilance Quality Management System (PV QMS) is the cornerstone of patient safety, regulatory compliance, and operational efficiency. As organizations expand into global markets,

In June 2025, the FDA announced the availability of a final guidance document containing questions and answers on conducting remote regulatory assessments (RRAs). Any examination, that is not on site, of the compliance of an agency-regulated establishment, or its records, is an RRA. The background section points out that they may request any records or

Quality Assurance (QA) teams play a critical role in ensuring compliance, maintaining regulatory integrity, and continuously improving organizational performance. However, the very nature of QA highlighting gaps, enforcing standards, and evaluating processes can often lead to friction, both within teams and with other stakeholders. In audit environments especially, these tensions can escalate, affecting team dynamics

The pharmaceutical industry is subject to stringent regulations that demand strict adherence to quality standards to ensure the safety and efficacy of medicinal products. The cost of quality (CoQ) plays a crucial role in balancing financial performance with quality assurance. Understanding CoQ enables businesses to enhance efficiency while maintaining compliance with Good Practices (GxP) and

The industry is looking at utilising available tools and technologies to be efficient and provide more accurate and reliable data in support of the regulatory requirements, eventually working towards data-backed information for the medical fraternity and the public. Blockchain offers a decentralised, uniformly distributed node-based database that protects data security and transparency. With the help

The process of performing audits has undergone a significant transition in our constantly changing digital age, where technology is changing how we work and interact. The concept of virtual audits was created because of this transformation’s increased reliance on digital tools and remote labour capabilities. These virtual audits have become a powerful and essential tool

The new UK Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024 introduce new requirements for manufacturers of medical devices in Great Britain. These requirements are designed to ensure that medical devices continue to be safe and effective throughout their lifetime. The 2024 amendment introduces a new Part 4A to the UK Medical Devices